Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001641172-25-025983
Filing Date
2025-08-29
Accepted
2025-08-29 16:05:28
Documents
1
Period of Report
2025-08-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2165
  Complete submission text file 0001641172-25-025983.txt   3896
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Issuer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 404 WASHINGTON AVE SUITE 650 MIAMI BEACH FL 33139
Business Address 404 WASHINGTON AVE SUITE 650 MIAMI BEACH FL 33139 786-381-2877
Lincoln Alternative Strategies LLC (Reporting) CIK: 0002043812 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0324
Type: 3 | Act: 34 | File No.: 001-36714 | Film No.: 251280817